Thursday, April 18 - Friday, April 19, 2024 - CANCELLED
- Cancellations received in writing at least 30 days prior to program date via letter or email to CE@cop.sc.edu will receive a full refund minus a $200 cancellation fee.
- All cancellations within 30 days prior to the start of the live component will receive NO refund. This includes those registering with a code for billing a third party after completing the training.
- USC COP reserves the right to cancel the entire program. In the event of a conference cancellation, each participant will be notified via phone and/or email at least 14 days prior to the program and a full tuition refund will be made.
- In the event of inclement weather, the decision to cancel a course will be made no later than 9:00 am Eastern time the day before the program.
- Individuals attending the course in place of the registered individual will be honored as long as the request is made in advance of the registration deadline, which is 7 days prior to the event.
- Refund requests are subject to a $200.00 cancellation fee and must be received 30 days prior to the start of the live component. All registration cancellations must be submitted in writing or by e-mail to the Continuing Education Department at the following address: University of South Carolina College of Pharmacy Continuing Education, 715 Sumter Street, Room 314B, Columbia, SC 29208, Email: CE@cop.sc.edu
- Registrants may receive 100% of the program registration fees, less the $200.00 cancellation fee up to 30 days prior to start date of the live component. No refunds are offered for cancellations fewer than 30 days prior to the start date of the live component or for no shows.
- Registration will be accepted until 15 days prior to the start of the program (Wednesday, April 3rd at 4:00pm) or until capacity has been reached.
- Assess the USP <797> requirements for facilities and engineering controls
- Evaluate the types and placement of primary engineering controls (PEC) for non-hazardous sterile compounding
- Implement a microbial air and surface monitoring program based on requirements for viable and non-viable sampling, including proper incubation periods
- Analyze microbial air and surface sampling results to identify potential issues related to cleaning activities and other sources of contamination
- Analyze the introduction of equipment and supplies into the cleanroom suite and PEC in order to minimize particle generation and risk of contamination to the cleanroom environment and sterile compounds
- Evaluate personnel performing hand hygiene, garbing, gloved fingertip and media fill sampling according to USP <797> requirements
- Analyze the elements of an effective cleaning and disinfectant program that complies with USP <797>
- Analyze a recertification report to identify the critical elements to ensure the environmental controls in the classified areas meet the minimal requirements of USP <797> or <800>
- Differentiate between the three categories of compounded sterile preparations as defined in USP <797>
- Evaluate sterilization methods for compounded sterile preparations prepared with nonsterile components or nonsterile supplies
- Evaluate aseptic process and sterilization methods as discussed in USP <797>
- Examine the personal protective equipment (PPE) requirements of USP <800>
- Analyze USP <800> requirements for deactivating, decontaminating, cleaning, and disinfecting
- Assess the USP <800> requirements for facilities and engineering controls
- Evaluate the types and placement of containment primary engineering controls (C-PEC) for hazardous compounding
- Examine the elements of hazardous risk based on USP <800> involved in creating an assessment of risk for your formulary
- Demonstrate spill management and disposal of hazardous drug waste
- Examine the role and accountabilities of the designated person per USP
Date: Apr 18, 2024 08:00 AM - Apr 19, 2024 05:30 PM
Fee
CE Hours
CE Units
Registration closes on Apr 03, 2024 04:00 PM
Activity Type
- Certificate-Based
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Registration closes on Apr 03, 2024
at 04:00 PM
Registration Closed
- Assess the USP <797> requirements for facilities and engineering controls
- Evaluate the types and placement of primary engineering controls (PEC) for non-hazardous sterile compounding
- Implement a microbial air and surface monitoring program based on requirements for viable and non-viable sampling, including proper incubation periods
- Analyze microbial air and surface sampling results to identify potential issues related to cleaning activities and other sources of contamination
- Analyze the introduction of equipment and supplies into the cleanroom suite and PEC in order to minimize particle generation and risk of contamination to the cleanroom environment and sterile compounds
- Evaluate personnel performing hand hygiene, garbing, gloved fingertip and media fill sampling according to USP <797> requirements
- Analyze the elements of an effective cleaning and disinfectant program that complies with USP <797>
- Analyze a recertification report to identify the critical elements to ensure the environmental controls in the classified areas meet the minimal requirements of USP <797> or <800>
- Differentiate between the three categories of compounded sterile preparations as defined in USP <797>
- Evaluate sterilization methods for compounded sterile preparations prepared with nonsterile components or nonsterile supplies
- Evaluate aseptic process and sterilization methods as discussed in USP <797>
- Examine the personal protective equipment (PPE) requirements of USP <800>
- Analyze USP <800> requirements for deactivating, decontaminating, cleaning, and disinfecting
- Assess the USP <800> requirements for facilities and engineering controls
- Evaluate the types and placement of containment primary engineering controls (C-PEC) for hazardous compounding
- Examine the elements of hazardous risk based on USP <800> involved in creating an assessment of risk for your formulary
- Demonstrate spill management and disposal of hazardous drug waste
- Examine the role and accountabilities of the designated person per USP
Speaker(s)/Author(s)
Allen Welch, PharmD
|
|
Eric Sparks
|
|
Richard Capps, PharmD
|
|
Shay Garrison, RPh, MPH
|